Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Tanita Thaweethamcharoen

Mahidol University, Thailand

Title: Experience about tool for quality of life measurement and economic evaluation for dialysis patient in the university hospital

Biography

Biography: Tanita Thaweethamcharoen

Abstract

Siriraj Hospital is the first university hospital in Thailand, with its vision to be the medical institute with international excellence in education, patient care, and research. Having about 2,100 inpatient beds, provides services to 80,000 admissions and over 3 million outpatients annually. Many health technology is offered to the hospital but the resource is limited thus Economic evaluation is an important tool involving examines consequences of the health care technology and evidence-based medicine in the hospital and societal perspective for policy decision. Economic evaluation research is one of the tools which impacts on decision making of treatments for individual patients because the result of the research concern both clinical outcome and ability to afford in the hospital or societal perspective. The results of the analysis can be a part of the process for the government decision, deciding whether drugs should be subsidized by the government, developing the intervention base on the cost effectiveness. The principles of economic evaluation and health technology assessment are the new challenge which can be applied to the processes as well as to improve patient care and will be useful in the overall movement towards the governance health care system. Role of the health care personnel cannot concern only the clinical outcome but healthcare expenditures also the important topic which are concerned so both of the effective and the expenditure should be considered. Our study start from the high expenditure of injectable drug; erythropoietin. Trend of Erythropoietin (EPO) expenditure was increasing between 2006 and 2009 and the highest expenditures for injectable drugs in 2009 of the large university hospital in Thailand. The major group of patient who use the erythropoietin is chronic kidney disease (CKD). CKD is the important chronic disease and the high expenditure in Thailand especially dialysis patient. Many tools of utility or the disease specific quality of life measurement were developed and applied in cost utility analysis to estimate the utility score and link to the QALYs which is one of the outcomes of the study. The results of the assessment since 2010 until the present are the evidence for many nephrologists and the Nephrology Society of Thailand to prioritize the health technology for health problem resolution and lead to an optimal care of people as well as good academic mission are challenge.